The DOI matches its Crossref record; 157 of the 161 references it cites were found in a registry or an index.
The role of microglia in amyloid clearance from the AD brain
Open accessAbstract
Alzheimer's disease (AD), the most prominent cause of senile dementia, is clinically characterized by the extracellular deposition of beta-amyloid (Abeta) and the intracellular neurofibrillary tangles. It has been well accepted that AD pathogenesis arises from perturbation in the homeostasis of Abeta in the brain. Abeta is normally produced at high levels in the brain and cleared in an equivalent rate. Thus, even a moderate decrease in the clearance leads to the accumulation of Abeta and subsequent amyloid deposition. Microglia are the tissue macrophages in the central nervous system (CNS) and have been shown to play major roles in internalization and degradation of Abeta. Abeta exists in the brain both in soluble and in fibrillar forms. Microglia interact with these two forms of Abeta in different ways. They take up soluble forms of Abeta through macropinocytosis and LDL receptor-related proteins (LRPs) mediated pathway. Fibrillar forms of Abeta interact with the cell surface innate immune receptor complex, initiating intracellular signaling cascades that stimulate phagocytosis. Inflammatory responses influence the activation status of microglia and subsequently regulate their ability to take up and degrade Abeta. ApoE and its receptors have been shown to play critical roles in these processes. In this review, we will explore the mechanisms that microglia utilize to clear Abeta and the effectors that modulate the processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence for a important role of microglial phagocytosis comes from studies that show that restricting microglial A uptake leads to increased cerebral A levels (El Khoury et al., 2007;Lee and Landreth, 2010).”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Lee and Landreth, 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microglial expression of receptors that promote the clearance and phagocytosis of A, such as CD36, TLR4, and TLR6 (Lee and Landreth, 2010), are mandatory for restricting amyloid plaque formation.”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Lee and Landreth, 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, microglia interacts with A through a recently characterized cell-surface receptor complex comprising CD36, ␣61 integrin, and CD47 (Lee and Landreth, 2010).”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Lee and Landreth, 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“For example, they facilitate the clearance of Aβ through phagocytosis42, yet they can also exacerbate neurodegeneration by driving persistent neuroinflammation43.”
From Deletion of SPI1 in microglia exacerbates amyloid pathology by impairing microglial response in Alzheimer’s disease models (2026) · cites this paper as [42]
The cited source says what the claim attributes to it.
In the citing paper
“Microglia, the innate immune cells of the brain, dynamically interact with these disease processes to influence AD progression.”
From PLCG2 modulates TREM2 expression and signaling in response to Alzheimer's disease pathology (2025) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Because microglia are critical for A phagocytosis, the microglial presence at the A plaque can be interpreted as an attempt to clear this pathological deposit.”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Lee and Landreth, 2010
The cited source says what the claim attributes to it.
In the citing paper
“However, persisting neuroinflammation and sustained exposure to proinflammatory stimuli compromises microglial clearance functions as AD progresses (Lee and Landreth, 2010).”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Lee and Landreth, 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045
Flagged first, then by citations
4 of the 161 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 701
Adipocyte metabolic state regulates glial phagocytic function
Alassaf, M., Madan, A., Ranganathan, S., Marschall, S., Wong, J. J., Goldberg, Z. H., Brent, A. E., & Rajan, A. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115704 · Cited by 7
Role of IRF4-Mediated Inflammation: Implication in Neurodegenerative Diseases
Liu, F. (2017) · Neurology & Neurotherapy Open Access Journal · doi:10.23880/nnoaj-16000107 · Cited by 5
An insight into Alzheimer’s disease and its on-setting novel genes
Vigneswaran, J., Muthukumar, S. A., Shafras, M., & Pant, G. (2021) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-021-00420-2 · Cited by 7
Hodgson, L. M., Li, Y., Iturria‐Medina, Y., Stratton, J. A., Wolf, G., Krishnaswamy, S., Bennett, D. A., & Bzdok, D. (2024) · Communications Biology · doi:10.1038/s42003-024-06273-8 · Cited by 7
Misfolded proteins as a therapeutic target in Alzheimer's disease
Liyanage, S. I., & Weaver, D. F. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.08.003 · Cited by 8
Redox modulation of the complement cascade contributes to synapse loss in Alzheimer's disease
Oh, C.-K., Wang, Y., & Lipton, S. A. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00707 · Cited by 6
Ms4a4a deficiency ameliorates plaque pathology in a mouse model of amyloid accumulation
Danhash, E., Verbeck, A. C., Western, D., Díaz‐Pacheco, A. S., Galasso, G., You, S., Huang, G., Starr, E., Miller, N., Nadarajah, C. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70580 · Cited by 6
FAAH Inhibition Counteracts Neuroinflammation via Autophagy Recovery in AD Models
Armeli, F., Coccurello, R., Giacovazzo, G., Mengoni, B., Paoletti, I., Oddi, S., Maccarrone, M., & Businaro, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212044 · Cited by 6
Xu, J., Zhao, Y., Wang, G., & Tian, W. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114281 · Cited by 7
Tsai, Y.-C., Luo, J.-C., Liu, T., Lu, I.-L., Shen, M., Chuang, C., Chern, C., & Chiu, H. (2020) · Nanomaterials · doi:10.3390/nano10071284 · Cited by 6
Balzamino, B. O., Esposito, G., Marino, R., Calissano, P., Latina, V., Amadoro, G., Keller, F., Cacciamani, A., & Micera, A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1015359 · Cited by 6
Braun, D. J., Frazier, H. N., Davis, V. A., Coleman, M. J., Rogers, C. B., & Eldik, L. J. V. (2023) · PLoS ONE · doi:10.1371/journal.pone.0286495 · Cited by 6
Neuroinflammation in Traumatic Brain Injury
Kuo, G. Y., Tarzi, F. P., Louie, S. G., & Poblete, R. A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105178 · Cited by 7
Rev-erbs and Glia—Implications for Neurodegenerative Diseases
Griffin, P. Y., Dimitry, J. M., & Musiek, E. S. (2019) · Journal of Experimental Neuroscience · doi:10.1177/1179069519853233 · Cited by 6
Kim, B., Tate, M. D., Karahan, H., Wijeratne, H. R. S., Sharify, A. D., Wang, S. S., Kim, J. R., Al-Amin, M. M., Hartigan, K., Chung, S., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.03.011 · Cited by 6
Rao, R., Verma, H., Gangwar, P., Yadav, A., Yadav, B., Patel, A., Kaur, S., Dhiman, M., & Mantha, A. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05435-x · Cited by 5
Baldasso, G. M., Paes, R. S., Moreira, A. F., Salvadori, S. G., Limberger, C., Roviezzo, F., Capasso, R., & Dutra, R. C. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108185 · Cited by 6
Jung, J., Kim, Y., Cirunduzi, A. C., Yoon, S., Bang, S., & Yang, S. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70919 · Cited by 5
Moser, V. A., Dimas‐Harms, L. J., Lipman, R. M., Inzalaco, J., Bell, S., Alcantara, M., Valenzuela, E., Lawless, G. M., Kreimer, S. D., Parker, S. J., et al. (2025) · Advanced Science · doi:10.1002/advs.202417848 · Cited by 5
A role of inflammasomes in the pathogenesis of neurological and mental diseases
Пирожков, С. В., Terebilina, N. N., & Litvitskiy, P. F. (2018) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201811812181 · Cited by 6
Szögi, T., Borbély, E., Schuster, I., Bozsó, Z., Sántha, M., Tóth, M. E., Penke, B., & Fülöp, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810364 · Cited by 6
Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?
Li, J., Huang, L., Liu, F., Tang, B., & Yan, X. (2017) · BMC Neurology · doi:10.1186/s12883-017-0942-y · Cited by 5
Druggable targets for the immunopathy of Alzheimer's disease
Weaver, D. F. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00096f · Cited by 5
Matsuse, D., Yamaguchi, H., Harada, M., Kira, Y., Nishimura, Y., Masaki, K., Tanaka, T., Saiga, T., Fujishima, K., Matsuo, E., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107206 · Cited by 3
Neuroinflammation demonstrated by 11 C‐ER176 PET with amyloid and tau pathology
Kandimalla, M., Lim, S., Jacobson, D. N., Lee, J., Min, P. H., Nycklemoe, M., Lee, S. B., Lundt, E. S., Botha, H., Graff‐Radford, J., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71027 · Cited by 4
Chockanathan, U., & Padmanabhan, K. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15636 · Cited by 6
Wang, Y., Xu, B., Zhou, J., Wang, J., Wang, G., & Cao, Y. (2021) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2021-020 · Cited by 5
Wu, F., Zhang, J., Wang, Q., Liu, W., Zhang, X., Ning, F., Cui, M., Qin, L., Zhao, G., Liu, D., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26304 · Cited by 5
Picard, K., Dolhan, K., Watters, J. J., & Tremblay, M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_20 · Cited by 4
Effect of the aggregation state of amyloid-beta (25-35) on the brain oxidative stress in vivo
Kozina, A., Herbert-Alonso, G., Díaz, A., Flores, G., & Guevara, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310258 · Cited by 5
Nathan, A. B. P., Aziz, A., Choi, S. M., Lee, S. H., Jeon, S., Kim, H.-S., Cho, J. H., & Jo, J. (2025) · Cells · doi:10.3390/cells14110826 · Cited by 4
Alzheimer’s Pathology: Should Peripheral Monocytes and CCR2 Take Center stage?
Harries, L. W., Pilling, L. C., Lampron, A., Rivest, S., & Melzer, D. R. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.72 · Cited by 4
Zhong, A., Tan, Y., Liu, Y., Chai, X., & Peng, W. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032814 · Cited by 4
Yoon, S., & Kim, Y. (2015) · Global Medical Genetics · doi:10.3934/genet.2015.3.230 · Cited by 5
Jeffrey, M., McGovern, G., Barron, R. M., & Baumann, F. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12173 · Cited by 4
Jin, S., Liu, Y., Deng, S., Lin, T., Rashid, A., Liao, L., Ning, Q., & Luo, X. (2015) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-015-1526-y · Cited by 4
Mitochondria at the Base of Neuronal Innate Immunity in Alzheimer’s and Parkinson’s Diseases
Esteves, A. R., Silva, D. F., Santos, D., Candeias, E., Filipe, F., & Cardoso, S. M. (2018) · InTech eBooks · doi:10.5772/intechopen.72612 · Cited by 4
Cannavo, C., Tosh, J., Fisher, E., & Wiseman, F. K. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.004 · Cited by 4
Henjum, K., Årskog, V., Jendresen, C., Fladby, T., Torp, R., & Nilsson, L. N. G. (2020) · Scientific Reports · doi:10.1038/s41598-020-67419-2 · Cited by 4
Mitochondrial control of microglial phagocytosis in Alzheimer’s diseasePreprint
Fairley, L. H., Lai, K. O., Wong, J. H., Salvatore, A. V., D’Agostino, G. A., Wu, X., Jayaraman, A., Langley, S. R., Ruedl, C., & Barron, A. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.01.469111 · Cited by 4
Corraliza-Gómez, M. (2021) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/51889 · Cited by 4
Zhang, Q., Lo, H., Song, Y., Feng, L., You, H., Chen, X., Wang, Y., & Pan, X. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03598-8 · Cited by 4
The Tetrapeptide HAEE Promotes Amyloid-Beta Clearance from the Brain
Mukhina, K. A., Varshavskaya, K. B., Rybak, A. D., Grishchenko, V. V., Kuzubova, E. V., Корокин, М. В., Kechko, O. I., & Mitkevich, V. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311591 · Cited by 4
Wu, F., Wang, D., Tabang, D. N., Liu, P.-K., Wang, Z., Liu, Y., Steenhagen, A., Puglielli, L., & Li, L. (2026) · Analytica Chimica Acta · doi:10.1016/j.aca.2026.345231 · Cited by 3
Yaghoubi, A. (2023) · Majallah-i dānishgāh-i ̒ulum-i pizishkī-i Kirmān. · doi:10.34172/jkmu.2023.23 · Cited by 3
Exploring the triad: VPS35 , neurogenesis, and neurodegenerative diseases
Qiu, Z., Deng, X., Fu, Y., Jiang, M., & Cui, X. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16184 · Cited by 3
Role of non-neuronal cells in neurorepair: a focus on proteinopathy and neurodegeneration
Rodríguez-Carreiro, S., Nogales, M. D. C., Jiménez-Galán, D., Carmona-Lorenzo, S., Caro-Martín, A., Navarro, E., & Esteras, N. (2024) · Regenerative medicine reports . · doi:10.4103/regenmed.regenmed-d-24-00005 · Cited by 2
Shi, J., Zhang, M., Hu, Y., Liu, J., Li, K., Sun, X., Chen, S., Liu, J., Ye, L., Fan, J., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106909 · Cited by 3
Garrahy, J. P. (2025) · Journal of Alzheimer’s Disease · doi:10.1177/13872877251350338 · Cited by 6
Hada, K., Murata, Y., Ohi, Y., Hashimoto, S., Watanabe, H., Ozeki, K., Saido, T. C., Saito, T., Sasaguri, H., Mizoguchi, H., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261415630 · Cited by 3
Sun, L., Dou, X., & Yang, W. (2022) · Folia Morphologica · doi:10.5603/fm.a2022.0027 · Cited by 3
Modifiable Innate Biology within the Gut–Brain Axis for Alzheimer’s Disease
Marcos-Pasero, H., García-Tejedor, A., Giménez‐Bastida, J. A., & Laparra, J. M. (2022) · Biomedicines · doi:10.3390/biomedicines10092098 · Cited by 3
Yamamoto, N., Tokumon, T., Obuchi, A., Kono, M., Saigo, K., Tanida, M., Ikeda‐Matsuo, Y., & Sobue, K. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15716 · Cited by 5
Lipid-nanoparticle-induced vacuolization in microglia
Kerschbaum, H., Gerner, C., Oberascher, K., Steiner, P., Schürz, M., & Bresgen, N. (2024) · Communications Biology · doi:10.1038/s42003-024-07271-6 · Cited by 2
Zhong, R., Chernick, D., Hottman, D. A., Tan, Y., Kim, M., Narayanan, M., & Li, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04859-9 · Cited by 4
Therapeutics of Alzheimer’s Disease
Herrera-Rivero, M., & Emiliano, G. (2011) · InTech eBooks · doi:10.5772/27990 · Cited by 3
Borsom, E. M., Conn, K. A., Keefe, C. R., Herman, C., Orsini, G. M., Hirsch, A. H., Avila, M. P., Testo, G., Jaramillo, S. A., Bolyen, E. K., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1538737/v1 · Cited by 3
Eskandari‐Sedighi, G., Crichton, M. C., Zia, S., Gomez, E., Laurent, C. D. S., Cortez, L. M., Patel, Z. H., Sidhu, G., Sarkar, S., Aghanya, V., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.04.547548 · Cited by 3
Zhang, Y., Wu, Y., Zhang, X., Guo, S., He, J., Hu, N., Huang, Y., Kong, Y., Li, Q., Sui, A., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70124 · Cited by 2
Amyloid and tau pathologies cross-talk to promote Alzheimeŕs disease: novel mechanistic insights
Ávila, J., Hernández, F., & Perry, G. L. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.07.025 · Cited by 3
Impaired TGFβ Signaling in Plaque-Associated Microglia
Krzyzan, O., Kuhla, A., Spittau, B., & Vidovic, N. (2026) · Biomolecules · doi:10.3390/biom16020248 · Cited by 3
Saha, S., Singam, A., White, M., Kimbel, C., Gopakumar, N., Kim, J. H., Chen, J., Salamat, A., & Park, S. (2026) · Biogerontology · doi:10.1007/s10522-026-10421-4 · Cited by 3
Powers, E. T., Elsasser, S., Stoeger, T., Cao, K., Collier, M., Rainbolt, T. K., Pokhrel, S., Taguwa, S., Sui, X., Kurtzbard, R. D., et al. (2026) · Autophagy · doi:10.1080/15548627.2026.2741033 · Cited by 2
Kanuri, S. H. (2024) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-024-00853-5 · Cited by 2
Duyckaerts, C. J. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660.007 · Cited by 2
Lyar Is a New Ligand for Retinal Pigment Epithelial Phagocytosis
Guo, F., Ding, Y., Caberoy, N. B., Alvarado, G., Liu, R., Shen, C., Yu, J., Zhou, Y., Salero, E., LeBlanc, M. E., et al. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25089 · Cited by 2
Giubilei, F. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160518122917 · Cited by 2
Passive Immunotherapy for Tau Pathology
Davies, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00014-9 · Cited by 2
Li, Y., Wu, Z.-Z., Wang, X.-S., Chen, X., Yu, J., Chen, H., Jia, X., & Zhang, Y. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.200813 · Cited by 2
Kemal, S., & Vassar, R. J. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20191536 · Cited by 2
Neuroinflammation in Alzheimer's Disease
(2020) · Case Medical Research · doi:10.31525/ct1-nct04274998 · Cited by 2
Tan, X.-X., Ma, H., Guo, X., Mao, M., Qiu, L., Dai, H., Dai, Y., Cao, J., Ma, H., & Sun, J. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137614 · Cited by 2
Ultrasonic Disruption of Circulating Amyloid β Aggregates Via Phase-Change Peptide Nanoemulsions
Kim, I., & Medina, S. H. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2025.123146 · Cited by 2
Stress oxydant et maladie d’Alzheimer
Gilbert, T., Drai, J., & Bonnefoy, M. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0443-9_10 · Cited by 2
Davalos, D., Akassoglou, K., & Cardona, A. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814405-3.00041-2 · Cited by 3
Chronic PPARγ Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves CognitionPreprint
Blume, T., Deußing, M., Biechele, G., Peters, F., Zott, B., Schmidt, C., Franzmeier, N., Wind-Mark, K., Eckenweber, F., Sacher, C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.30.446348 · Cited by 2
Preventive Effects of Dairy Products on Dementia and Cognitive Decline
Yun, J.-H., Seol, K., Yoo, J., Oh, M., & Ham, J.-S. (2020) · Journal of Dairy Science and Biotechnology · doi:10.22424/jdsb.2020.38.1.27 · Cited by 1
Role of Noncoding RNAs in Modulating Microglial Phenotype
Meer, E. (2024) · Global Medical Genetics · doi:10.1055/s-0044-1790283 · Cited by 1
Freyssin, A., Carles, A., Moha, B., Rubinstenn, G., & Maurice, T. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00522 · Cited by 1
Peyvand, P., Allami, P., & Rezaei, N. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2025-0025 · Cited by 1
Zhu, X., Diep, Y. N., Tran, V. T. A., Kang, Y. J., Lee, L. P., & Cho, H. (2025) · BioChip Journal · doi:10.1007/s13206-025-00228-9 · Cited by 1
EGR2 maintains neuropathic pain by promoting microglial phagocytosis.
Xi, C., Zhang, J., Huang, Z., He, L., Zou, K., Xu, X., Guo, Q., Sun, B., & Huang, C. (2025) · PubMed Central · doi:10.11817/j.issn.1672-7347.2025.240270 · Cited by 1
Free radical-scavenging and anti-amyloidogenic properties of chicoric acid
He, M. T., Cho, E. J., Kim, J. H., & Kim, H. Y. (2025) · Applied Biological Chemistry · doi:10.1186/s13765-025-01047-0 · Cited by 1
Su, B., Dong, W., Su, L., Ye, J., Yao, Q., Liu, M., Wu, J., & Du, K. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108344 · Cited by 2
Liu, M., Hu, Y., Xu, M.-D., Chen, Y., & Meng, Q.-B. (2026) · Food & medicine homology. · doi:10.26599/fmh.2027.9420146 · Cited by 4
Bellver‐Sanchís, A., Ralchev, N., Romanska, P. R., Dyakova, N. K., Ivanova, K. I., Griñán‐Ferré, C., & Marchev, A. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177833 · Cited by 1
Alzheimer’s Disease and Mechanism-Based Attempts to Enhance Cognition
Draffin, J. E., Knafo, S., & Heneka, M. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417042-1.00009-7 · Cited by 1
Fang, M., Cheng, I. H.-J., & Chen, C.-L. (2022) · Fermentation · doi:10.3390/fermentation8050193 · Cited by 1
Electron microscopist's view of the Alzheimer's plaque
Dikranian, K. T. (2012) · Biomedical Reviews · doi:10.14748/bmr.v23.25 · Cited by 1
Contribution of Neuroinflammation in the Pathogenesis of Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00006-9 · Cited by 1
Xavier, A. M., Belhocine, S., & Gosselin, D. (2019) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1449 · Cited by 1
Nanocomposites Facilitate the Removal of Aβ Fibrils for Neuroprotection
Chai, J., Li, Q., Zhao, Y., & Liu, Y. (2021) · Chemical Research in Chinese Universities · doi:10.1007/s40242-021-1372-3 · Cited by 1
Neсroptosis and the experience of its targeted modulation in the context of personalized medicine
Dmitriev, Y. V., & Galagudza, M. M. (2022) · Russian Journal for Personalized Medicine · doi:10.18705/2782-3806-2022-2-2-33-45 · Cited by 1
E2F4 as a single multifactorial target against Alzheimer’s diseasePreprint
López‐Sánchez, N., Ramón‐Landreau, M., Trujillo, C., Garrido‐García, A., & Frade, J. M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.08.082784 · Cited by 1
Brain geometry matters in Alzheimer’s disease progression: a simulation studyPreprint
Hoore, M., Kelling, J., Sayadmanesh, M., Mitra, T., Schips, M., & Meyer‐Hermann, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.24.220228 · Cited by 1
Yaghoubi, A. (2021) · Research Square · doi:10.21203/rs.3.rs-427829/v1 · Cited by 1
Concomitant AD and DLB pathologies shape subfield microglia responses in the hippocampusPreprint
Fixemer, S., Ameli, C., Hammer, G. P., Salamanca, L., Huarte, O. U., Schwartz, C., Gérardy, J., Mechawar, N., Skupin, A., Mittelbronn, M. G. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.06.475218 · Cited by 1
Role of microglia in myelin turnover
Safaiyan, S. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5727
The effects of whole-body vibration on brain functions
Oroszi, T. (2023) · doi:10.33612/diss.560228188 · Cited by 1
Tutrow, K. D., Harkin, J., Varghese, L., Hernandez, M., Huang, K.-C., Fang, Y., Wilcox, P., Bedford, L. M., Lin, T., Zhang, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.01.662163 · Cited by 1
Metadata
- Authors
- Lee, C. Y. D., & Landreth, G. E.
- Affiliations
- Case Western Reserve University (US)
- Corresponding author
- Landreth, Gary E.
- ORCID
- Landreth, Gary E.
- Venue
- Journal of Neural Transmission
- Published
- 2010-06-15
- Volume
- 117
- Issue
- 8
- Pages
- 949-960
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- PMC
- PMC3653296
- OpenAlex
- W2038594716
- Cited by
- 701
- References
- 161
- Citations by year
- 2026: 26 · 2025: 49 · 2024: 74 · 2023: 54 · 2022: 66 · 2021: 50 · 2020: 51 · 2019: 43 · 2018: 56 · 2017: 31 · 2016: 29 · 2015: 43 · 2014: 35 · 2013: 36 · 2012: 31
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG020202, R01AG030482, R01AG016740)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- microglia, amyloid-beta clearance, Alzheimer's disease, amyloid deposition, macropinocytosis, LDL receptor-related protein, phagocytosis, innate immune receptors, inflammation, microglial activation, apolipoprotein E, amyloid clearance
- MeSH terms
- Alzheimer Disease, Amyloid, Apolipoproteins E, Brain, Humans, Inflammation, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
